Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Biography
Marc Klapholz, MD, FACC, FSCAI is Professor & Chair, Department of Medicine, Chief of Service and Director, Division of Cardiology at Rutgers - New Jersey Medical School in New Jersey. He also serves as the Director of the Heart Failure Prevention and Treatment Program.
Dr. Klapholz received his medical degree from the Albert Einstein College of Medicine, Bronx, New York. He completed his residency in internal medicine, an NIH sponsored Heart Failure Research Fellowship, General Cardiology and Interventional Cardiology Fellowship at the Albert Einstein College of Medicine and Bronx Municipal Hospital Center. He is board certified in Internal Medicine, Cardiovascular Disease, Echocardiography and Interventional Cardiology and Heart Failure & Transplant.
Dr. Klapholz has been a principal investigator on over 100 clinical trials in heart failure and other cardiovascular diseases. He serves on AHA Grant Review Committees, the Heart Failure Society of America Guidelines Committee and on the Editorial Board of several journals. He has been the chairman and member of numerous Steering, Endpoint and Data Safety Monitoring Board Committees for national and international trials in heart failure.
His major research interests include the evaluation of novel therapeutic agents and devices for the treatment of heart failure. He has authored and co-authored numerous articles, book chapters, monographs, and reviews in cardiovascular disease.
Dr. Klapholz received his medical degree from the Albert Einstein College of Medicine, Bronx, New York. He completed his residency in internal medicine, an NIH sponsored Heart Failure Research Fellowship, General Cardiology and Interventional Cardiology Fellowship at the Albert Einstein College of Medicine and Bronx Municipal Hospital Center. He is board certified in Internal Medicine, Cardiovascular Disease, Echocardiography and Interventional Cardiology and Heart Failure & Transplant.
Dr. Klapholz has been a principal investigator on over 100 clinical trials in heart failure and other cardiovascular diseases. He serves on AHA Grant Review Committees, the Heart Failure Society of America Guidelines Committee and on the Editorial Board of several journals. He has been the chairman and member of numerous Steering, Endpoint and Data Safety Monitoring Board Committees for national and international trials in heart failure.
His major research interests include the evaluation of novel therapeutic agents and devices for the treatment of heart failure. He has authored and co-authored numerous articles, book chapters, monographs, and reviews in cardiovascular disease.
Research Interest
Heart Diseases, Heart Failure, Myocardial Infarction, Pediatric Cardiology, Arteriosclerosis, Echocardiography, Arrhythmia, Cardiovascular Imaging, Cardiomyopathy, Atrial Fibrillation, Cardiac Transplantation, Geriatric Cardiology, Arrhythmia, Cardiovascular Medicine
Publications
-
Impact of Genetic Factors in Cardiovascular Disease
Short Communication: Int J Cardiol Res
DOI:
Sarah Chen